We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.65%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$59.5B
AUM Growth
+$3.71B
Cap. Flow
+$2.71B
Cap. Flow %
4.55%
Top 10 Hldgs %
19.97%
Holding
3,755
New
295
Increased
1,969
Reduced
1,191
Closed
173

Sector Composition

Rank Sector Weight
1 Technology 10.24%
2 Financials 9.05%
3 Healthcare 7.82%
4 Industrials 6.6%
5 Energy 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIAB
3476
CALL
DELISTED
Viacom Inc. Class B
VIAB
$21K ﹤0.01%
83,600
-700
-0.8% -$20.6K
SXE
3477
DELISTED
Southcross Energy Partners, L.P.
SXE
$21K ﹤0.01%
13,411
-300
-2% -$490
ALT icon
3478
Altimmune
ALT
$599M
$20K ﹤0.01%
1,486
+230
+18% +$4.53K
XLE icon
3479
CALL
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
$20K ﹤0.01%
55,800
+400
+0.7% +$14.9K
CMCSA icon
3480
CALL
Comcast
CMCSA
$90B
$19K ﹤0.01%
+25,600
New +$834K
DFS
3481
CALL
DELISTED
Discover Financial Services
DFS
$19K ﹤0.01%
24,100
-600
-2% -$44K
ORCL icon
3482
CALL
Oracle
ORCL
$423B
$19K ﹤0.01%
285,000
+22,600
+9% +$1.04M
IMBI
3483
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$18K ﹤0.01%
1,430
IDXG
3484
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$18K ﹤0.01%
2,000
WMT icon
3485
CALL
Walmart Inc
WMT
$890B
$17K ﹤0.01%
61,200
+4,500
+8% +$128K
CANF
3486
Can-Fite BioPharma American Depositary Shares
CANF
$7.37M
$16K ﹤0.01%
5
ROX
3487
DELISTED
Castle Brands, Inc.
ROX
$16K ﹤0.01%
13,800
+3,000
+28% +$3.72K
MO icon
3488
CALL
Altria Group
MO
$114B
$15K ﹤0.01%
27,900
+2,700
+11% +$156K
BBY icon
3489
CALL
Best Buy
BBY
$17.3B
$14K ﹤0.01%
21,400
CB icon
3490
CALL
Chubb
CB
$135B
$14K ﹤0.01%
39,400
-8,600
-18% -$1.14M
ETN icon
3491
CALL
Eaton
ETN
$174B
$14K ﹤0.01%
106,700
-11,400
-10% -$882K
SNGX icon
3492
Soligenix
SNGX
$5.81M
$14K ﹤0.01%
61
BAC icon
3493
CALL
Bank of America
BAC
$442B
$13K ﹤0.01%
88,200
-12,500
-12% -$373K
EGO icon
3494
Eldorado Gold
EGO
$9.89B
$13K ﹤0.01%
2,522
-1,372
-35% -$7.05K
PE
3495
CALL
DELISTED
PARSLEY ENERGY INC
PE
$13K ﹤0.01%
+15,000
New +$442K
PLM
3496
DELISTED
PolyMet Mining Corp.
PLM
$13K ﹤0.01%
1,350
FURY
3497
Fury Gold Mines
FURY
$114M
$12K ﹤0.01%
5,017
CYTR
3498
DELISTED
CytRx Corp
CYTR
$12K ﹤0.01%
10,607
+228
+2% +$341
GG
3499
CALL
DELISTED
Goldcorp Inc
GG
$12K ﹤0.01%
31,700
CLDX icon
3500
Celldex Therapeutics
CLDX
$3.28B
$11K ﹤0.01%
1,419
-179
-11% -$2.39K

Similar funds

Raymond James & Associates's Q2 2018 Portfolio in Review

As of Q2 2018, Raymond James & Associates held 3,755 positions worth $59.5B, up 6.7% from $55.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.71B of net new capital in Q2 2018, opening 295 new positions and adding to 1,969 existing holdings. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 727,426 shares worth $45.6M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $97.9M trimmed.

  • Raymond James & Associates's largest Q2 2018 buy was Vanguard Intermediate-Term Treasury ETF: 727,426 shares worth $45.6M.
  • Raymond James & Associates added most to iShares Core MSCI EAFE ETF in Q2 2018, an estimated $167M increase.
  • Raymond James & Associates's biggest Q2 2018 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $97.9M.
  • Raymond James & Associates fully exited Time Warner Inc in Q2 2018, selling an estimated $118M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $59.5B portfolio in Q2 2018.
  • Raymond James & Associates opened 295 new positions and closed 173 in Q2 2018.
  • Raymond James & Associates's portfolio value rose 6.7% quarter-over-quarter to $59.5B.

Based on Raymond James & Associates's 13F filing for Q2 2018, filed 14 Aug 2018.